Patents Assigned to PHEON THERAPEUTICS LTD
  • CYTOTOXIC AGENTS
    Publication number: 20240109916
    Abstract: The invention relates to a compound of formula (I) or formula (II) or pharmaceutically acceptable salts, solvates, tautomers, stereoisomers or mixtures thereof; which are useful as medicaments, in particular as anti-proliferative agents and for use as a drug in an antibody-drug conjugate and in the treatment of proliferative diseases.
    Type: Application
    Filed: September 27, 2022
    Publication date: April 4, 2024
    Applicant: PHEON THERAPEUTICS LTD
    Inventors: Paul Joseph Mark JACKSON, David Edwin THURSTON, Khondaker Mirazur RAHMAN
  • Anti-proliferative agents comprising substituted benzo[e]pyrido[1,2-a][1,4]diazepines
    Patent number: 11912700
    Abstract: The invention relates to substituted pyrridinobenzodiazepines (PDDs) of formula (XV) and pharmaceutically acceptable salts thereof, which are useful as medicaments, in particular as anti-proliferative agents.
    Type: Grant
    Filed: February 24, 2021
    Date of Patent: February 27, 2024
    Assignee: PHEON THERAPEUTICS LTD
    Inventors: Paul Joseph Mark Jackson, David Edwin Thurston, Khondaker Mirazur Rahman